Skip to main content
. 2021 Jun 1;11:11450. doi: 10.1038/s41598-021-90975-0

Table 5.

Haplotype analysis in patients with CAD and control subjects.

Haplotype SNP2 SNP4 Control, n (%) (n = 1082) CAD, n (%) (n = 950) OR[95%CI] P value
H1 C A 1488.21 (0.69) 1354.26 (0.71) 1.13 [0.99–1.29] 0.082
H2 C G 13.79 (0.01) 23.74 (0.01) 1.97 [1.01–3.84] 0.042*
H3 T A 553.79 (0.26) 473.74 (0.25) 0.97 [0.84–1.11] 0.630
H4 T G 108.21 (0.05) 48.26 (0.03) 0.49 [0.35–0.70]  < 0.001*

SNP2: rs2483205; SNP4: rs562556. *: p < 0.05.